Stem Cell Transplant clinical trials

Explore recruiting stem cell transplant clinical trials.

Recruiting stem cell transplant studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Stem Cell Transplant trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Randomized, Open-Label Study Of Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)

Spain, Belgium, Germany, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A MULTICENTRIC PHASE 2 STUDY OF VENETOCLAX AND AZACITIDINE FOR THE MANAGEMENT OF MOLECULAR RELAPSE/PROGRESSION IN ADULT NPM1-MUTATED ACUTE MYELOID LEUKEMIA. AML2521

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Pharmacokinetics of anti-lymphocyte serum in the prevention of GvHD in children and adults receiving allogeneic hematopoietic stem cell transplantation - PHASAL-GA Study

France

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Ravulizumab in Adult and Adolescent Participants who have Thrombotic Microangiopathy (TMA) after Hematopoietic Stem Cell Transplant (HSCT)

Germany, Poland, France, Spain, Sweden, Belgium +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Vaccination against human papillomavirus (HPV) after allogeneic stem cell transplantation, a randomized study between early and late vaccination.

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase Ib study of Vyxeos® (liposomal daunorubicin and cytarabine) in combination with Clofarabine in children with relapsed/refractory AML

Netherlands, Austria, Italy, Germany, Spain, Denmark

Human Pharmacology (Phase I)- Other EU CTIS Study details

Stem Cell Transplant trials by city

Stem Cell Transplant in Toronto Stem Cell Transplant in Vancouver Stem Cell Transplant in Montreal Stem Cell Transplant in Calgary Stem Cell Transplant in Edmonton Stem Cell Transplant in Ottawa Stem Cell Transplant in Winnipeg Stem Cell Transplant in Quebec City Stem Cell Transplant in Hamilton Stem Cell Transplant in Kitchener Stem Cell Transplant in London Stem Cell Transplant in Halifax Stem Cell Transplant in New York Stem Cell Transplant in Los Angeles Stem Cell Transplant in Chicago Stem Cell Transplant in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease